rs41265125
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000751.3(CHRND):c.821-37G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0803 in 1,382,740 control chromosomes in the GnomAD database, including 4,838 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.072 ( 364 hom., cov: 29)
Exomes 𝑓: 0.081 ( 4474 hom. )
Consequence
CHRND
NM_000751.3 intron
NM_000751.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.278
Publications
5 publications found
Genes affected
CHRND (HGNC:1965): (cholinergic receptor nicotinic delta subunit) The acetylcholine receptor of muscle has 5 subunits of 4 different types: 2 alpha and 1 each of beta, gamma and delta subunits. After acetylcholine binding, the receptor undergoes an extensive conformation change that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. Defects in this gene are a cause of multiple pterygium syndrome lethal type (MUPSL), congenital myasthenic syndrome slow-channel type (SCCMS), and congenital myasthenic syndrome fast-channel type (FCCMS). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2015]
CHRND Gene-Disease associations (from GenCC):
- congenital myasthenic syndrome 3AInheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- congenital myasthenic syndrome 3BInheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp
- congenital myasthenic syndrome 3CInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- lethal multiple pterygium syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 2-232531315-G-A is Benign according to our data. Variant chr2-232531315-G-A is described in ClinVar as Benign. ClinVar VariationId is 256782.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0997 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CHRND | NM_000751.3 | c.821-37G>A | intron_variant | Intron 7 of 11 | ENST00000258385.8 | NP_000742.1 | ||
| CHRND | NM_001256657.2 | c.776-37G>A | intron_variant | Intron 6 of 10 | NP_001243586.1 | |||
| CHRND | NM_001311196.2 | c.518-37G>A | intron_variant | Intron 7 of 11 | NP_001298125.1 | |||
| CHRND | NM_001311195.2 | c.239-37G>A | intron_variant | Intron 5 of 9 | NP_001298124.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0717 AC: 9007AN: 125560Hom.: 364 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
9007
AN:
125560
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0700 AC: 16601AN: 237190 AF XY: 0.0732 show subpopulations
GnomAD2 exomes
AF:
AC:
16601
AN:
237190
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0811 AC: 102010AN: 1257068Hom.: 4474 Cov.: 20 AF XY: 0.0821 AC XY: 51964AN XY: 633060 show subpopulations
GnomAD4 exome
AF:
AC:
102010
AN:
1257068
Hom.:
Cov.:
20
AF XY:
AC XY:
51964
AN XY:
633060
show subpopulations
African (AFR)
AF:
AC:
371
AN:
28080
American (AMR)
AF:
AC:
1963
AN:
43898
Ashkenazi Jewish (ASJ)
AF:
AC:
2594
AN:
23798
East Asian (EAS)
AF:
AC:
664
AN:
37936
South Asian (SAS)
AF:
AC:
7127
AN:
81076
European-Finnish (FIN)
AF:
AC:
3362
AN:
48552
Middle Eastern (MID)
AF:
AC:
635
AN:
4880
European-Non Finnish (NFE)
AF:
AC:
81091
AN:
936154
Other (OTH)
AF:
AC:
4203
AN:
52694
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
5277
10554
15831
21108
26385
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2774
5548
8322
11096
13870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0716 AC: 9003AN: 125672Hom.: 364 Cov.: 29 AF XY: 0.0701 AC XY: 4307AN XY: 61436 show subpopulations
GnomAD4 genome
AF:
AC:
9003
AN:
125672
Hom.:
Cov.:
29
AF XY:
AC XY:
4307
AN XY:
61436
show subpopulations
African (AFR)
AF:
AC:
550
AN:
31218
American (AMR)
AF:
AC:
888
AN:
13322
Ashkenazi Jewish (ASJ)
AF:
AC:
369
AN:
2774
East Asian (EAS)
AF:
AC:
59
AN:
4854
South Asian (SAS)
AF:
AC:
424
AN:
3918
European-Finnish (FIN)
AF:
AC:
584
AN:
8658
Middle Eastern (MID)
AF:
AC:
34
AN:
232
European-Non Finnish (NFE)
AF:
AC:
5788
AN:
58104
Other (OTH)
AF:
AC:
144
AN:
1742
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
443
886
1328
1771
2214
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.